These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 6245567

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin-induced prostacyclin release may contribute to the hypotensive action of converting enzyme inhibitors.
    Dusting GJ, Mullins EM, Doyle AE.
    Adv Prostaglandin Thromboxane Res; 1980; 7():815-9. PubMed ID: 6245570
    [No Abstract] [Full Text] [Related]

  • 3. Release of prostacyclin into the bloodstream in humans after local blood flow changes.
    Serneri GC, Masotti G, Poggesi L, Galanti G.
    Adv Prostaglandin Thromboxane Res; 1980; 7():715-8. PubMed ID: 6989198
    [No Abstract] [Full Text] [Related]

  • 4. Prostacyclin-release by bradykinin in vivo [proceedings].
    Moncada S, Mullane KM, Vane JR.
    Br J Pharmacol; 1979 May; 66(1):96P-97P. PubMed ID: 378310
    [No Abstract] [Full Text] [Related]

  • 5. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
    Brown NJ, Ryder D, Gainer JV, Morrow JD, Nadeau J.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
    [Abstract] [Full Text] [Related]

  • 6. Prostacyclin release and the modulation of some vasoactive hormones.
    Mullane KM, Moncada S.
    Prostaglandins; 1980 Jul; 20(1):25-49. PubMed ID: 6996037
    [Abstract] [Full Text] [Related]

  • 7. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D, Santos RA, Etelvino GM, Xavier CH, de Almeida Santos J, Mendes EP, Machado LT, Prezoto BC, Dive V, de Camargo AC.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
    Gallois H, Piot O.
    N Engl J Med; 1999 Mar 25; 340(12):968-9. PubMed ID: 10094650
    [No Abstract] [Full Text] [Related]

  • 11. The response of the rat duodenum to bradykinin.
    Montgomery EH.
    Proc West Pharmacol Soc; 1968 Mar 25; 11():51-2. PubMed ID: 5734484
    [No Abstract] [Full Text] [Related]

  • 12. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE.
    Prog Biochem Pharmacol; 1980 Mar 25; 17():29-35. PubMed ID: 7010367
    [Abstract] [Full Text] [Related]

  • 13. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF, Pessa LR, Tanus-Santos JE.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):173-7. PubMed ID: 19233159
    [Abstract] [Full Text] [Related]

  • 14. Hypoventilation and elevation of end-expiratory pressure release a substance which relaxes isolated arteries and disaggregates platelets in the presence of cyclooxygenase inhibitors.
    Herbaczynska-Cedro K, Truskolaski P, Huszczuk A, Dusting GJ.
    Prostaglandins; 1981 May 01; 21(5):707-17. PubMed ID: 7041193
    [Abstract] [Full Text] [Related]

  • 15. [Effects of bradykinin in the cardiovascular effects of angiotensin-converting enzyme inhibitors].
    Galinier M, Pathak A, Baixas C, Alhabaj S, Fallouh V, Roncali J, Schmutz L, Massabuau P, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 2002 Feb 01; 95 Spec 4(5 Spec 4):37-40. PubMed ID: 11933554
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes.
    Yeung JH.
    Methods Find Exp Clin Pharmacol; 1994 Apr 01; 16(3):163-72. PubMed ID: 8046949
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M, Bara AT, Busse R.
    Eur Heart J; 1993 Nov 01; 14 Suppl I():161-3. PubMed ID: 8293768
    [Abstract] [Full Text] [Related]

  • 18. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R, Fleming I, Hecker M.
    J Cardiovasc Pharmacol; 1993 Nov 01; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [Abstract] [Full Text] [Related]

  • 19. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI, Clappison B, McGrath BP, Matthews PG, Millar JA, Anderson WP.
    Prog Biochem Pharmacol; 1980 Nov 01; 17():123-33. PubMed ID: 6259649
    [No Abstract] [Full Text] [Related]

  • 20. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Lévy BI, Michel JB.
    Br J Pharmacol; 1997 May 01; 121(1):83-90. PubMed ID: 9146891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.